Linking Ubiquitin Research to Drug Discovery

Home » News & Events » News

Ubiquitin focused drug discovery

Posted on August 3rd, 2017 in News
Targeting kinase enzymes has grown to dominate drug discovery over the last decade, accounting for 30% of current pharma R&D Click on the link below to download our brochure detailing "The Unbiquitin System" and how "The analogous ubiquitin cell signalling… Read More »

DUBtarget™-001 – a novel DUB focused compound library

Posted on August 3rd, 2017 in News
The first compound library comprising novel small molecules designed to target deubiquitylase enzymes Click on the link below to download a non-confidential summary of DUBtarget™-001 which includes details of how the library was designed and characterised by screening it using… Read More »

Ubiquigent awarded Innovate UK grant

Posted on January 19th, 2017 in News
Ubiquigent awarded Innovate UK grant to develop novel compound libraries targeting deubiquitylase (DUB) enzymes Dundee, UK, 19th January 2017: Ubiquigent Limited, a company specialising in providing ubiquitin cell-signalling system drug discovery services and research tools, announced today that it has… Read More »

Ubiquigent launches first novel compound library

Posted on September 14th, 2016 in News
Ubiquigent launches the first novel compound library designed to target Deubiquitylase (DUB) enzymes - DUBtarget™-001 Dundee, UK, 14th September, 2016: Ubiquigent Limited, a company specialising in providing ubiquitin cell-signalling system drug discovery services and research tools, announced today that it… Read More »

Horizon & Ubiquigent Enter into Collaboration Agreement

Posted on May 26th, 2016 in News
Horizon's X-MAN® cell lines to be made available in conjunction with Ubiquigent's ubiquitin-related Drug Discovery Services   Cambridge, UK, 26 May 2016: Horizon Discovery Group plc (LSE: HZD) ("Horizon"), the world leader in the application of gene editing technologies including… Read More »

Dundee, UK – the place to access world class ubiquitin system research expertise and capabilities

Posted on May 12th, 2016 in News
Take a look at a great article that was published today in Nature describing how the Division of Signal Transduction Therapy (DSTT) enables pre-competitive access to ubiquitin system research at the University of Dundee. Our friends at the University of… Read More »

Ubiquigent Strengthens Team to Deliver Cutting Edge Drug Discovery Services, Research Tools and Chemistry and Announces Launch of New Website

Posted on February 24th, 2016 in News
Dundee, UK, 24th February, 2016: Ubiquigent Limited, a company specialising in providing ubiquitin cell-signalling system drug discovery services and research tools, announced today that it has significantly enhanced its drug discovery service capabilities by strengthening its commercial and chemistry teams… Read More »

Ubiquigent and Cyclofluidic Enter into Collaboration to Build Novel Ubiquitin System Targeted Compound Libraries

Posted on June 3rd, 2015 in News
Agreement combines ubiquitin focused biology expertise with proprietary chemistry platform to identify small molecule libraries that target the ubiquitin system. Dundee, UK, 3rd June 2015: Ubiquigent Limited, a company specialising in ubiquitin cell-signalling system drug discovery capabilities and services, and… Read More »

Exclusive collaboration with UbiQ to commercialise novel reagents for Parkinson’s Disease research

Posted on April 29th, 2015 in News
Ubiquigent announces an exclusive collaboration with UbiQ to commercialise novel reagents addressing a new frontier of integrated ubiquitylation and phosphorylation research central to Parkinson's Disease Dundee, UK, 29 April 2015: Ubiquigent Limited, a company specialising in providing ubiquitin cell signalling… Read More »

Dr Achim Werner awarded the Ubiquigent Young Scientist Prize

Posted on October 24th, 2014 in News
Dr Achim Werner awarded the Ubiquigent Young Scientist Prize at the EMBO-CONICET meeting on 'Ubiquitin and ubiquitin-like proteins: at the crossroads from chromatin to protein" Dundee, UK, 24th October 2014 - Ubiquigent Ltd. is delighted to announce that Dr Achim Werner was awarded… Read More »